The Downstream Processing Market is entering a high-stakes expansion phase driven by surging biopharmaceutical production, intensified demand for monoclonal antibodies, and rapid scale-up of cell and ...

Process intensification has reduced the cost of mAb manufacturing, but tweaks across bioproduction will be needed to reduce ...

Over two-thirds of biopharmaceutical manufacturers now report that their facility is experiencing capacity bottlenecks due to downstream processing. A number of factors continue to converge to create ...

Purifying novel therapeutics remains a major challenge as increasingly complex molecules move towards the clinic. With Lonza, you can ensure optimal product quality and bring your molecules to the ...

This session will explore how integrating Ready Made Solutions can help streamline downstream bioprocessing by reducing complexity and increasing efficiency for MSAT and production teams. Together, ...

Lindian Resources Ltd (ASX:LIN, OTC:LINIF) has fully entered construction mode at its flagship Kangankunde Rare Earths ...

Biopharmaceutical downstream processing requires precise control of multiple unit operations—from chromatography and filtration to viral inactivation—to ensure product quality and therapeutic efficacy ...

Petróleo Brasileiro SA (Petrobras) has signed a contract to sell its 5,800-b/d Unidade de Industrialização do Xisto (SIX) unit—including a mine in one of the world’s largest oil shale reserves and a ...

LEWES, Del., April 15, 2026 /PRNewswire/ -- The Global Downstream Processing Market is projected to grow at a CAGR of 6.8% from 2026 to 2033, according to a new report published by Verified Market ...